Plain-English translation of NCT04014413 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor's stool into your digestive system. The goal is to restore a balanced community of gut bacteria, which researchers believe may help treat a wide range of conditions—from inflammatory bowel diseases and infections to metabolic disorders and even autoimmune conditions. While early research shows promise, this trial aims to confirm whether this treatment is safe and effective in real clinical settings.
Growing evidence suggests that imbalances in gut bacteria (called dysbiosis) play a role in many diseases. Although the treatment has shown encouraging results in small studies, doctors need larger, well-designed studies to confirm that this approach is truly safe and works across different patient groups.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic to receive the fecal microbiota transplant, which involves introducing healthy stool from a screened donor into your digestive system—typically through a procedure like a colonoscopy, endoscopy, or a tube inserted through your nose. The study team will monitor you before and after the procedure to check whether the treatment helps your symptoms and whether you experience any side effects. The exact schedule and follow-up visits will depend on your specific condition and the study protocol.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Hong Kong